Quick Answer
Cullinan Therapeutics, Inc. reported Common Stock Shares Outstanding of 60.24 million shares for the year ending 2025.
- Cullinan Therapeutics, Inc. showed an increase of +3.0% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Cullinan Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 10, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 6 years of available data (2020 to 2025), Cullinan Therapeutics, Inc.'s Common Stock Shares Outstanding has grown by 102.0%.
- Historical annual values: Fiscal year 2025: 60.24 million shares | Fiscal year 2024: 58.51 million shares | Fiscal year 2023: 42.90 million shares | Fiscal year 2022: 45.80 million shares | Fiscal year 2021: 44.29 million shares | Fiscal year 2020: 29.83 million shares.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: